The renal effects of mineralocorticoid receptor antagonists

Area of Science:

• Nephrology
• Endocrinology
• Pathophysiology

Background:

• Aldosterone classically regulates renal water and electrolyte balance.
• Emerging evidence implicates aldosterone in kidney disease pathogenesis and progression.
• Aldosterone exerts deleterious effects on various kidney cell types, including podocytes and mesangial cells.

Purpose of the Study:

• To review evidence supporting aldosterone's independent role in kidney damage.
• To summarize interventional studies on aldosterone antagonism in kidney disease.
• To highlight the therapeutic potential of blocking aldosterone pathways.

Main Methods:

• Review of experimental and clinical studies on aldosterone's renal effects.
• Analysis of data on aldosterone's impact on podocyte injury, mesangial cell proliferation, and tubulointerstitial inflammation.
• Evaluation of interventional studies using aldosterone antagonists.

Main Results:

• Aldosterone binding induces podocyte apoptosis, mesangial cell changes, and tubulointerstitial inflammation.
• Aldosterone contributes to glomerular fibrosis and sclerosis.
• Aldosterone antagonists show potential in retarding kidney disease progression, independent of blood pressure effects.

Conclusions:

• Aldosterone plays an independent role in inducing kidney damage in human and experimental models.
• Blockade of the aldosterone pathway represents a potentially beneficial therapeutic strategy for kidney disease.
• Targeting aldosterone may favorably modify the decline of renal function in patients with kidney and associated extrarenal diseases.